PANews June 18 news, the U.S. Nasdaq-listed company Eyenovia, which focuses on the development of digital ophthalmic medical technology, announced the completion of a $50 million PIPE financing, which will be used to purchase the Hyperliquid native token HYPE, and plans to become one of its main global validation nodes. This transaction is expected to have a total fundraising cap of $150 million, and the company will also be renamed 'Hyperion DeFi', with the stock code changing to 'HYPD'. The new Chief Investment Officer Hyunsu Jung will be responsible for executing the cryptocurrency treasury strategy. Eyenovia will also continue to advance its ophthalmic device FDA registration plan, aiming to complete it by September 2025.